Justin Brownlee Faces New Doping Challenge Amid Career Setbacks
Source: news.source.mb
Justin Brownlee, the import for Barangay Ginebra and a key player for Gilas Pilipinas, has received a 'notice of adverse analytical finding' from the Samahang Basketbol ng Pilipinas (SBP). The nature of the substance involved has not been disclosed, and no official ruling has been issued by FIBA as of yet. Brownlee, who recently suffered a dislocated thumb and a third PBA Finals loss, is navigating this new challenge with the help of his US-based lawyers. This incident follows a previous three-month suspension in 2023 due to testing positive for 'Carboxy-THC'.
Key Points
Justin Brownlee received a 'notice of adverse analytical finding' from SBP on March 31, 2025.
The specific substance involved in the finding has not been disclosed.
No official ruling has been issued by FIBA regarding this incident.
Brownlee is currently dealing with the situation with the help of his US-based lawyers.
This is not Brownlee's first encounter with doping issues; he was previously suspended for three months in 2023 after testing positive for 'Carboxy-THC'.
Brownlee has been playing non-stop basketball, including for Gilas in the FIBA Olympic Qualifiers and Asia Cup qualifiers.
